Charles A. Deignan - Dec 20, 2022 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Role
Chief Financial Officer
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol
CLSD
Transactions as of
Dec 20, 2022
Transactions value $
$9,454
Form type
4
Date filed
12/20/2022, 03:38 PM
Previous filing
Jan 28, 2022
Next filing
Jan 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLSD Common Stock Options Exercise $9.45K +23.6K +6.68% $0.40 378K Dec 20, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLSD Employee Stock Option (right to buy) Options Exercise $0 -23.6K -100% $0.00* 0 Dec 20, 2022 Common Stock 23.6K $0.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested and exercisable.